|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-16
|
|
pubmed:abstractText |
Seventy per cent of postmenopausal women suffer from hot flushes causing significant morbidity in 25%. Oestrogen replacement provides symptom relief, but its use has declined following safety issues and there is, as yet, no good alternative. Pathophysiology is poorly understood, but one proposed mechanism is altered peripheral vascular reactivity. It has recently been suggested that the presence of flushing may be a marker of underlying cardiovascular risk.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1365-2265
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 Blackwell Publishing Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
97-103
|
|
pubmed:meshHeading |
pubmed-meshheading:21050255-Acetylcholine,
pubmed-meshheading:21050255-Aged,
pubmed-meshheading:21050255-Apolipoprotein A-I,
pubmed-meshheading:21050255-Cardiovascular Diseases,
pubmed-meshheading:21050255-Cholesterol, HDL,
pubmed-meshheading:21050255-Endothelium, Vascular,
pubmed-meshheading:21050255-Female,
pubmed-meshheading:21050255-Hot Flashes,
pubmed-meshheading:21050255-Humans,
pubmed-meshheading:21050255-Iontophoresis,
pubmed-meshheading:21050255-Middle Aged,
pubmed-meshheading:21050255-Nitroprusside,
pubmed-meshheading:21050255-Risk Factors,
pubmed-meshheading:21050255-Vasodilator Agents
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Vascular function and cardiovascular risk factors in women with severe flushing.
|
|
pubmed:affiliation |
Centre for Population & Health Sciences, University of Glasgow, UK. jenifer.sassarini@glasgow.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
